logo

For the Inventor, By the Inventor

Piscataway, NJ, United States of America

Hemantbhai Patel

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Agenebio, Inc., Seton Hall University, US Government as Represented by the Secretary of the Army. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hemantbhai Patel. Retrieved from https://idiyas.com/inventor/hemantbhai-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal4 out of 14 
 
Agenebio, Inc.
 patents
silverMedal3 out of 12 
 
Seton Hall University
 patents
bronzeMedal1 out of 8,745 
 
US Government as Represented by the Secretary of the Army
 patents
where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...
7 patents (USPTO):Explore Patents
1. 12528819 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2026-01-20),
2. 12291535 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2025-05-06),
3. 11505555 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2022-11-22),
4. 11414425 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2022-08-16),
5. 9956549 - Stabilized and reactive fluorinated phthalocyanine-functionalized solid-state support composites (2018-05-01),
6. 9731284 - Process for oxidation of amines in the synthesis of energetic materials (2017-08-15),
7. 9572898 - Functionalized fluorine containing phthalocyanine molecules (2017-02-21),

Title: Hemantbhai Patel: A Visionary Inventor in the Field of Cognitive Impairment Treatment

Introduction:

Hemantbhai Patel, a prolific inventor based in Piscataway, NJ, has made significant contributions to the field of treating cognitive impairment associated with central nervous system disorders. With a total of 5 patents to his name, his innovative work has garnered attention in the scientific community.

Latest Patents:

One of Hemantbhai Patel's latest patents involves Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment. This invention focuses on utilizing α5-containing GABA receptor agonists in treating a wide range of CNS disorders, including Alzheimer's Disease, Parkinson's Disease, schizophrenia, and brain cancers like medulloblastomas. The methods outlined in this patent offer promising treatment options for various cognitive impairments.

Career Highlights:

Having worked at renowned institutions like Seton Hall University and Agenebio, Inc., Hemantbhai Patel has showcased his expertise in pharmacology and neuroscience. His innovative research has paved the way for novel treatment modalities in the realm of cognitive impairment, earning him recognition in the industry.

Collaborations:

Throughout his career, Hemantbhai Patel has collaborated with esteemed professionals in the field, including Sergiu M. Gorun and Belew Mekonnen. These collaborations have led to fruitful endeavors that have advanced the understanding and treatment of cognitive disorders.

Conclusion:

In conclusion, Hemantbhai Patel stands as a trailblazer in the field of cognitive impairment treatment. His patented inventions demonstrate a deep understanding of CNS disorders and a commitment to improving the lives of individuals affected by cognitive impairments. Hemantbhai Patel's contributions serve as a beacon of innovation and progress in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…